Skip to main content

Sherri C. Oberg '82 Tuck '86

Sherri ObergVice Chair and co-founder
Acusphere, Inc.

Lexington, Massachusetts

Elected 2008 (Charter Trustee)
A.B. Dartmouth College
M.B.A. Tuck School of Business

Sherri C. Oberg is Vice Chair and co-founder of Acusphere, Inc., a specialty pharmaceutical company with a broad technology that has generated four drug candidates which have entered human clinical trials. As President and CEO until 2013, she was responsible for conceiving the strategy, business plan and product concepts. She hired a highly experienced senior management team and grew the company to over 100 employees. She oversaw the development of a novel cardiovascular drug from prototype development and animal testing through the final stages of human trials and commercial manufacturing scale-up to support applications which are now on file for regulatory approval in Europe and the U.S. She closed partnerships with U.S. and European pharmaceutical companies totaling more than $100 million in upfront fees and milestone payments, raised over $300 million in equity financing including $100 million in venture capital, an initial public offering (IPO) and over $200 million in public equity. She began her career in venture capital at Inco Venture Capital Management and later moved to Aegis Venture Funds. She has also served on the boards of directors of the Massachusetts Biotechnology Council as well as the Massachusetts Medical Device Industry Council (MassMEDIC).

Oberg was a history major at Dartmouth and earned her MBA from the Amos Tuck School of Business. She is Chair of the Audit Committee and also a member of Tuck's Board of Overseers. Previously, she was on the Advisory Board of the Tuck Center for Private Equity and Entrepreneurship and was President of Dartmouth's Alumni Council. She is a recipient of Dartmouth's Young Alumni Distinguished Service Award and the Tuck Overseers Medal. She is married to another Dartmouth graduate, Curt Oberg '78 and they have two children.

Last Updated: 11/25/13